Jeffrey Stephens
Psychiatry · Greenville, SCNPI 1417900846
Payments from drug & device makers
Across 803 payments — averaging $242.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$134K
- Supernus Pharmaceuticals, Inc.$55K
- Ironshore Pharmaceuticals Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$903
- Tris Pharma Inc$582
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$528
- plus $3K from 22 others
What the payments were for
- Speaking & faculty fees$181,50593%
- Travel & lodging$2,1181%
- Food & beverage$11,2016%
- Education$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 189 | $133,618 |
| Supernus Pharmaceuticals, Inc. | 198 | $54,916 |
| Ironshore Pharmaceuticals Inc. | 114 | $1,183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 64 | $903 |
| Tris Pharma Inc | 29 | $582 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $528 |
| Vanda Pharmaceuticals Inc. | 23 | $393 |
| Otsuka America Pharmaceutical, Inc. | 20 | $362 |
| Corium, LLC | 17 | $353 |
| Bausch Health US, LLC | 17 | $290 |
| Neos Therapeutics, LP | 17 | $253 |
| Sunovion Pharmaceuticals Inc. | 16 | $242 |
| Lundbeck LLC | 17 | $236 |
| Collegium Pharmaceutical, Inc. | 16 | $186 |
| Almatica Pharma LLC | 7 | $145 |
| Noven Therapeutics, LLC | 7 | $143 |
| Idorsia Pharmaceuticals US Inc | 6 | $128 |
| Axsome Therapeutics, Inc. | 5 | $124 |
| Alkermes, Inc. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Johnson & Johnson | 3 | $46 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Rhodes Pharmaceuticals L.p. | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$194,887 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FanaptIloperidone | 33 | $77,526 |
| VraylarCariprazine Hcl | 25 | $35,431 |
| Lurasidone Hcl | 42 | $19,473 |
| TrintellixVortioxetine Hydrobromide | 17 | $15,547 |
| BelsomraSuvorexant | 23 | $9,699 |
| VyvanseLisdexamfetamine Dimesylate | 17 | $6,430 |
| AzstarysSerdexmethylphen/Dexmethylphen | 12 | $4,805 |
| Aripiprazole | 46 | $4,507 |
| Bupropion XlBupropion Hcl | 198 | $3,386 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 99 | $3,094 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 24 | $2,369 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 27 | $2,312 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 58 | $2,217 |
| Vilazodone Hcl | 30 | $2,201 |
| Lamotrigine | 192 | $2,043 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Vanda Pharmaceuticals Inc.Fanapt | $393 | $77,52633 claims |
| AbbVieVraylar | $133,618 | $35,43125 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $903 | $21,97734 claims |
| Corium, LLCAzstarys | $353 | $4,80512 claims |
| Almatica Pharma LLCSertraline Hcl | $145 | $40145 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Greenville
- Robert RichardsGreenville$142K
- Lisa WischhusenGreenville$14K
- Jeffrey SmithGreenville$10K
- Lauren LevyGreenville$7K
- Jacobo MintzerCharleston$4.9M
- Paul RobbinsSummerville$1.2M
- Brittany AlbrightMount Pleasant$691K
- Eduardo CifuentesCharleston$675K
- Veronica RidpathFlorence$364K
- Mark GeorgeCharleston$332K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.